HK Stock MarketDetailed Quotes

SUNSHINE PHARMA (06887)

Watchlist
  • 42.560
  • -1.120-2.56%
Not Open Apr 22 16:01 CST
24.51BMarket Cap81.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SUNSHINE PHARMA (06887) Earnings Dates, Reports & Conference Call

06887 2025 Annual Earnings Dates & Summary

Currency：CNYMar 31, 2026

Estimate
(YoY) 		Actual
(YoY) 		Vs Estimate
(% Chg)
Revenue
--
4.82B
--
+19.81%
Net Income
--
270.03M
--
+988.72%
Analyst Rating
Strong Buy

Apr 22, 2026

06887 Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/H22.452B / 823.000M--
--2019/H13.071B / ----
DatePeriodRevenue/EstimateEarnings Call
--2022/H22.452B / 823.000M--
--2019/H13.071B / ----
--------
--------
--------

Unlock Free Earnings Estimates

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -2.38%
Sample Name
Sample Code
 -3.85%
Sample Name
Sample Code
 -5.38%
4
CHINA OILFIELD
02883
-9.61%
5
KUNLUN ENERGY
00135
-9.64%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +26.88%
Sample Name
Sample Code
 +18.89%
Sample Name
Sample Code
 +17.81%
4
Business-intelligence Of Oriental Nations Corporation
300166
+16.81%
5
Ucloud Technology Co., Ltd
688158
+15.18%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -